#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial hypertriglyceridaemia Infertility female Immune thrombocytopenia Neuroblastoma Fibrosarcoma metastatic Sarcoma Brain stem glioma Adrenogenital syndrome Myotonic dystrophy Meningococcal immunisation Loeys-Dietz syndrome Intracranial calcification Waldenstrom's macroglobulinaemia recurrent Cytokine release syndrome Hyperadrenocorticism More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Diagnostics Hereditary optic atrophy Systemic mastocytosis – Basic Information Immunodeficiency congenital – Treatment Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics Testicular leiomyosarcoma – Life with Disease Amyotrophic lateral sclerosis – Treatment Cerebral arteriovenous malformation haemorrhagic – Basic Information Turner’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iron Sucrose A24110He TTX-381 Pentixather Vb10.16 Durvalumab Crovalimab Poloxamer 407 Lovo-A Human Cancellous Bone Mk-1200 Df6002 Infliximab SKB410 VTX-002 Nazartinib Lutetium (177Lu) Edotreotide Quercetin Hydroxychloroquine Sulfate M-(18F)-Fluorobenzylguanidine More therapies…

    Learn about Your Condition

    Urticaria chronic Stomatitis T-cell type acute leukaemia Arrhythmia supraventricular Postprandial hypoglycaemia Ovarian cancer recurrent Nasopharyngeal cancer Renal failure Pleomorphic leiomyosarcoma Hepatic adenoma Hepatic fibrosis Barrett's oesophagus Behavioural addiction Obstructive airways disorder Cervix carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement

    Recruiting

    2 1 1
    Investigated Drugs:
    • Xtmab-16
    Czechia Denmark Italy Poland Spain

  • Study on Regorafenib with Cyclophosphamide, Capecitabine, and Aspirin for Patients with Metastatic Colorectal Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • D,L-Lysine Acetylsalicylate
    • Regorafenib
    France

  • Study of JNJ-90301900 with Chemoradiation and Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • HAFNIUM OXIDE
    France The Netherlands Spain

  • Study on the Safety and Effects of YTB323 and Drug Combination for Patients with Treatment-Resistant Generalized Myasthenia Gravis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Cyclophosphamide
    • Fludarabine Phosphate
    • Human Normal Immunoglobulin (Iv)
    France

  • Study on Zoledronic Acid for Healing After Rotator Cuff Surgery in Patients with Tendon Rupture and Osteoporosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Tendon injury
    Investigated Drugs:
    • Zoledronic Acid
    Austria

  • Study on Dalteparin Sodium and Enoxaparin Sodium for Preventing Blood Clots in Patients Undergoing Liver Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dalteparin Sodium
    • Enoxaparin Sodium
    Norway
Previous Page
1 … 281 282 283 284 285 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!